Thyme Care closes $95M Series C to advance optimization of care, navigation

Published by Cancer Letter on Jul 31, 2024 10:10:32 AM

Thyme Care announced the close of a $95 million capital raise. With $55 million in equity funding, Thyme Care welcomes new investor Concord Health Partners with participation from all existing investors, including CVS Health Ventures, Town Hall Ventures, a16z Bio + Health, AlleyCorp, Echo Health Ventures, Frist Cressey Ventures, and Foresite Capital.